Login
← Go Back
Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023
Stock Price vs Company Growth
1d
1.3%
1w
1.4%
1m
1.5%
3m
16.6%
6m
34.9%
all
66.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,368 1.3%
1,980
2,489
Company Overview
Sales
9,946 Cr
Growth: 17.1%
Profit after Tax
1,727 Cr
Growth: 10.9%
Large Cap
94,869 Cr
P/E: 55.0x
Industry P/E: 35.5x
Fundamentals
Sales (Cr) ₹ 9,946
Growth 17.1%
EBITDA 23.7%
P/S 9.5x
Dividend 0.0%
P/E 55.0x
Book Value ₹ 222
PEG Ratio 3.2x
ROE 21.2%
P/B 10.7x
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Belongs to (19 Indices) view more
Investors (1)
samrocks...